A detailed history of Xtx Topco LTD transactions in Virios Therapeutics, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 42,650 shares of VIRI stock, worth $7,250. This represents 0.0% of its overall portfolio holdings.

Number of Shares
42,650
Holding current value
$7,250
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$0.18 - $0.58 $7,677 - $24,737
42,650 New
42,650 $9,000
Q4 2023

Feb 13, 2024

BUY
$0.46 - $0.9 $3,826 - $7,487
8,319 Added 57.61%
22,760 $12,000
Q3 2023

Nov 13, 2023

SELL
$0.86 - $2.42 $1,713 - $4,823
-1,993 Reduced 12.13%
14,441 $13,000
Q2 2023

Aug 14, 2023

BUY
$0.35 - $1.94 $5,751 - $31,881
16,434 New
16,434 $22,000

Others Institutions Holding VIRI

About Virios Therapeutics, Inc.


  • Ticker VIRI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 18,330,400
  • Market Cap $3.12M
  • Description
  • Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It is also developing IMC...
More about VIRI
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.